Observational studyJAMA network open2025

Trastuzumab Deruxtecan for ERBB2-Mutant Metastatic Non-Small Cell Lung Cancer With or Without Brain Metastases: A Secondary Analysis of Randomized Clinical Trials.

Pasi A Jänne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.